James H. Stanker, Chief Financial Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 1,000 shares at $6.81 ($7K) on 2021-06-21, disclosed to the SEC on 2021-06-22.
Open-market purchase of $7k PCSA by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |